In two studies, semaglutide failed to slow decline in thousands of people with early stages of Alzheimer's disease.

Scientists have long recognized that conditions affecting the body can also influence the brain. Issues such as obesity, high blood pressure and ...

Lecanemab, also known by its brand name Leqembi, is a treatment for Alzheimer’s disease that helps remove toxic plaques from ...

The Centers for Medicare & Medicaid Services announced Nov. 25 that Medicare recipients will pay less for 15 prescription ...

The Trump administration says pharmaceutical companies have agreed to slash the Medicare prices for 15 prescription drugs ...

The Trump administration said that had the new prices been in effect last year, Medicare would have saved $12 billion, which ...

The lower prices stem from the Medicare negotiation program created under the Biden administration's Inflation Reduction Act.

The Trump administration tapped a Biden-era rule to negotiate lower prices on 15 widely used medications for seniors.

Every day, our brains transform quick impressions, flashes of inspiration, and painful moments into enduring memories that ...

The two neurodegenerative diseases could not appear more different. Amyotrophic lateral sclerosis (ALS), sometimes called Lou ...

Emerging evidence suggests there may be a critical window for estrogen therapy to protect against cognitive decline later in ...